Transcriptomics

Dataset Information

0

BCLXL PROTAC degrader DT2216 targets secondary plasma cell leukemia addicted to BCLXL for survival


ABSTRACT: We demonstrated that secondary Plasma Cell Leukemia, addicted to BCLXL, a small but a very challenging group of patients, could benefit from DT2216, underpinning its clinical evaluation.

ORGANISM(S): Homo sapiens

PROVIDER: GSE222016 | GEO | 2024/01/30

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

| PRJNA917319 | ENA
| S-EPMC10393035 | biostudies-literature
| S-EPMC9887192 | biostudies-literature
| PRJNA539941 | ENA
| S-EPMC6757289 | biostudies-literature
| S-EPMC9489811 | biostudies-literature
| S-EPMC9667539 | biostudies-literature
| S-EPMC8083113 | biostudies-literature
| S-EPMC9189076 | biostudies-literature
| S-EPMC8608744 | biostudies-literature